Literature DB >> 16920724

Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process.

M Torricelli1, G De Falco, P Florio, M Rossi, E Leucci, P Viganò, L Leoncini, F Petraglia.   

Abstract

BACKGROUND: Urocortin (UCN) gene expression and synthesis have been reported in epithelial and stromal cells of the human endometrium. In this study we evaluated (i) UCN messenger RNA (mRNA) expression and peptide production in uterine specimens collected throughout the endometrial cycle, (ii) UCN secretion after decidualization of cultured human endometrial stromal cells (HESCs) and (iii) the effect of UCN on endometrial decidualization.
METHODS: HESCs were isolated from samples of human endometrium collected from healthy patients with normal menstrual cycle and cultured in presence of cAMP, 17-beta-estradiol (E(2)) + medroxyprogesterone acetate (MPA) and UCN. UCN levels were measured in endometrial extracts by an enzyme immunoassay, and changes of endometrial UCN mRNA expression were measured by RT-PCR analysis.
RESULTS: UCN peptide concentrations and mRNA expression were highest in the secretory phase of the menstrual cycle (P < 0.001, late secretory versus early and late proliferative phase) and higher in the late than the early secretory phase (P < 0.01). After decidualization of HESC with cAMP or E(2) + MPA, UCN levels rose in parallel with prolactin concentrations by days 6 (P < 0.01, for all). Finally, the addition of UCN to HESCs, with or without E(2) + MPA, induced the release of prolactin.
CONCLUSIONS: The evidence that (i) UCN is highly expressed in the secretory phase of the endometrial cycle; (ii) cAMP and E(2) + MPA modulate secretion of UCN and (iii) UCN induces HESCs decidualization together suggest a possible role for UCN in endometrial physiology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920724     DOI: 10.1093/humrep/del331

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Evaluation of the Ki-67 Proliferation Index and Urocortin Expression in Women with Ovarian Endometriomas.

Authors:  Serenat Eris Yalcin; Irfan Ocal; Yakup Yalcin; Halime Sen Selim; Melike Demir Caltekin; Huseyin Aydogmus; Sefa Kelekci
Journal:  Eurasian J Med       Date:  2017-06

2.  Attenuated tubal and endometrial urocortin 1 and corticotropin-releasing hormone receptor expression in ectopic pregnancy.

Authors:  L E Borges; A W Horne; S E McDonald; J L V Shaw; P C Lourenco; F Petraglia; H O D Critchley
Journal:  Reprod Sci       Date:  2010-10-26       Impact factor: 3.060

Review 3.  Role of urocortin in pregnancy: An update and future perspectives.

Authors:  Salvatore Giovanni Vitale; Antonio Simone Laganà; Agnese Maria Chiara Rapisarda; Maria Giovanna Scarale; Francesco Corrado; Pietro Cignini; Salvatore Butticè; Diego Rossetti
Journal:  World J Clin Cases       Date:  2016-07-16       Impact factor: 1.337

4.  Galectin-1 overexpression in endometriosis and its regulation by neuropeptides (CRH, UCN) indicating its important role in reproduction and inflammation.

Authors:  Aikaterini Vergetaki; Udo Jeschke; Thomas Vrekoussis; Eirini Taliouri; Luca Sabatini; Evangelia A Papakonstanti; Antonis Makrigiannakis
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

5.  Differential expression of CRH, UCN, CRHR1 and CRHR2 in eutopic and ectopic endometrium of women with endometriosis.

Authors:  Aikaterini Vergetaki; Udo Jeschke; Thomas Vrekoussis; Eirini Taliouri; Luca Sabatini; Evangelia A Papakonstanti; Antonis Makrigiannakis
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

Review 6.  Corticotropin-Releasing Factor Family: A Stress Hormone-Receptor System's Emerging Role in Mediating Sex-Specific Signaling.

Authors:  Lahari Vuppaladhadiam; Cameron Ehsan; Meghana Akkati; Aditi Bhargava
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.